Redhill Biopharma
RDHL
52 hedge funds and large institutions have $65M invested in Redhill Biopharma in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 6 closing their positions.
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
73% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 11
11% more funds holding
Funds holding: 47 → 52 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
2% less call options, than puts
Call options by funds: $2.2M | Put options by funds: $2.26M
16% less capital invested
Capital invested by funds: $77.5M → $65M (-$12.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.99M |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$404K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$404K |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$396K |
| 5 |
GS
Gagnon Securities
New York
|
+$387K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.19M |
| 2 |
DGI
Disciplined Growth Investors
Minneapolis,
Minnesota
|
-$737K |
| 3 |
CG
Colony Group
Boston,
Massachusetts
|
-$327K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$207K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$162K |
RDHL Hedge Fund Activity: Q4 2020 in Review
52 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q4 2020, worth a combined $65M — down 16% from $77.5M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new RDHL positions and 6 closed out — a net gain of 5 holders — while 19 added to existing stakes and 11 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $2.99M. The largest seller was Schonfeld Strategic Advisors, cutting an estimated $1.19M.
- 52 institutional investors held Redhill Biopharma (RDHL) as of Q4 2020, up from 47 in Q3 2020.
- Funds reported $65M of Redhill Biopharma stock for Q4 2020, down 16% quarter-over-quarter.
- 11 funds opened new Redhill Biopharma positions in Q4 2020 and 6 closed out, a net change of +5 holders.
- The largest Redhill Biopharma buyer in Q4 2020 was BlackRock, an estimated $2.99M added.
- The largest Redhill Biopharma seller in Q4 2020 was Schonfeld Strategic Advisors, an estimated $1.19M sold.
Based on aggregated 13F filings for Q4 2020.